Glipizide Tablet, Extended Release
Product Images NDC 60760-794

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 60760-794). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

794-30 (Glipizide 60760 794 30)

794-30 (Glipizide 60760 794 30)
This is a description for a medication package of Glipizide Extended-Release Tablets in 5mg strength, with a quantity of 30 tablets. The product has an NDC code of 60760-794-30 and is manufactured in India. The package also includes lot numbers and expiration dates. The medication is for oral use and should be stored at a controlled room temperature between 15°-30°C (59°-86°F). Contact number for Managed Pharmacy Programs is provided for further assistance.*
FDA Label Image

Chemical Structure (Glipizide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.